A Comprehensive Guide to the mylife Loop: Simplifying Diabetes Management

The mylife™ Loop is a cutting-edge automated insulin delivery (AID) system developed by Ypsomed, a trusted Swiss company with over 35 years of expertise in diabetes care. Designed to offer convenience and improved glucose control, the mylife™ Loop integrates advanced technology with a user-friendly approach, making it a popular choice for individuals with type 1 diabetes.

What Is the mylife™ Loop?

The mylife™ Loop system is a hybrid closed-loop AID system that combines the mylife™ YpsoPump insulin pump, the mylife™ CamAPS FX mobile app, and compatible Continuous Glucose Monitors (CGMs). It automates insulin delivery based on real-time glucose data, significantly reducing the manual workload of managing diabetes.

Ypsomed, founded in 1984, has a proven track record in developing innovative, patient-centric diabetes solutions.

Specifications

Here are the key technical details of the mylife™ Loop system:

Size: 3.07 x 1.81 x 0.63 inches (7.8 x 4.6 x 1.6 cm)
Weight: 2.93 ounces (83 grams), including the battery and a filled cartridge
Cartridge Size: 1.6 mL of insulin
Basal Rates: Two customizable profiles with adjustable rates
Bolus Delivery: Options include standard, extended, combination, and blind boluses, ranging from 0.1 to 30.0 units
Increment Sizes: Bolus increments of 0.1, 0.5, 1.0, or 2.0 units
Water Resistance: Not explicitly specified

How It Works

The mylife™ Loop utilizes the mylife™ CamAPS FX algorithm to automate insulin delivery every 8–12 minutes based on glucose readings from a CGM. The algorithm adapts to the user’s unique needs over time, offering precise insulin adjustments to help maintain optimal glucose levels.

This system’s algorithm, developed by CamDiab Ltd, is one of the few approved for use in children as young as one year old and pregnant women with type 1 diabetes.

Target Glucose Levels

The mylife™ Loop allows users to personalize their glucose targets based on clinical recommendations. While specific targets vary, the system is designed to keep glucose levels within a safe range for general use and exercise.

Regulatory Status

As of June 2023, the mylife™ Loop system is available in most European countries, including France, Norway, Spain, and Italy.
The device is pending approval in Canada and is under review by the FDA for potential availability in the United States.

Cost and Availability

Pricing for the mylife™ Loop depends on the region, healthcare providers, and insurance coverage. Patients are advised to contact Ypsomed or their healthcare provider for detailed cost information.

What’s Included?

When you purchase the mylife™ Loop, you’ll receive:

mylife™ YpsoPump insulin pump
mylife™ CamAPS FX mobile application
Compatible CGM system (Dexcom G6 or FreeStyle Libre 3) Ypsomed also offers comprehensive training to ensure users feel confident operating the system.

Compatibility

The mylife™ Loop works with the Dexcom G6 and FreeStyle Libre 3 CGM systems, allowing users to choose their preferred glucose monitoring device.

Mobile App and Remote Access

The mylife™ CamAPS FX app is the central hub for controlling bolus delivery, monitoring glucose data, and adjusting basal and bolus settings. Through the app’s remote monitoring feature, users can also share data with up to 10 companions, such as caregivers or healthcare professionals.

Battery Maintenance

The mylife™ YpsoPump uses a replaceable battery, providing convenience for users. The replaceable design ensures uninterrupted functionality. Specific battery life details are unavailable.

Pros and Cons

Pros:

User-friendly interface and app-based control
Compatibility with multiple CGM systems
Suitable for a broad range of users, including children and pregnant women
Remote monitoring features for caregivers

Cons:

Limited availability in some regions pending regulatory approvals

Conclusion:

The mylife™ Loop is an innovative and flexible AID system tailored to the diverse needs of people with type 1 diabetes. Automating insulin delivery and offering app-based control empowers users to achieve better glucose management with less effort. For more details, visit the Ypsomed website or consult your healthcare provider.